These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3381631)

  • 1. Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up.
    van't Verlaat JW; Nortier JW; Hendriks MJ; Bosma NJ; Graamans K; Lubsen H; Vasen HF; Thijssen JH; Croughs RJ
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):154-8. PubMed ID: 3381631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
    Arafah BU; Brodkey JS; Kaufman B; Velasco M; Manni A; Pearson OH
    J Clin Endocrinol Metab; 1980 Mar; 50(3):578-85. PubMed ID: 6244327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients.
    Roelfsema F; van Dulken H; Frölich M
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):555-65. PubMed ID: 4085133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acromegaly by transsphenoidal microsurgery.
    Giovanelli MA; Motti ED; Paracchi A; Beck-Peccoz P; Ambrosi B; Faglia G
    J Neurosurg; 1976 Jun; 44(6):677-86. PubMed ID: 818343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
    Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgery or microsurgery in the management of acromegaly.
    Teasdale GM; Hay ID; Beasttall GH; McCruden DC; Thomson JA; Davies DL; Grossart KW; Ratcliffe JG
    JAMA; 1982 Mar; 247(9):1289-91. PubMed ID: 7062545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977.
    Laws ER; Piepgras DG; Randall RV; Abboud CF
    J Neurosurg; 1979 Apr; 50(4):454-61. PubMed ID: 423000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly.
    Bynke O; Karlberg BE; Kågedal B; Nilsson OR
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):158-62. PubMed ID: 6858550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels.
    Biermasz NR; Dulken HV; Roelfsema F
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.
    De Marinis L; Mancini A; Zuppi P; Anile C; Maira G
    Acta Endocrinol (Copenh); 1990 Apr; 122(4):443-9. PubMed ID: 2110409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
    Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
    J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
    Valdemarsson S; Ljunggren S; Cervin A; Svensson C; Isaksson A; Nordström CH; Siesjö P
    Scand J Clin Lab Invest; 2001; 61(6):459-70. PubMed ID: 11681536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients.
    Ross DA; Wilson CB
    J Neurosurg; 1988 Jun; 68(6):854-67. PubMed ID: 3373281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
    van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.